Accidental innovation and cancer research

Through a process of serendipitous innovation, a team of biomedical researchers at the University of Rochester

Medical Center in New York may have discovered a new

way to attack cancerous tumor growths

. It turns out that what researchers originally thought was a "lab disaster" may actually be a new compound that breaks down the cell walls of tumors. The researchers will test the new compound for safety in the hope of developing it to treat cancers such as colon cancer,

esophageal cancer, liver and skin cancers. It all started when the researchers decided to use cancer cells instead of normal human cells:

Normal human cells are difficult to grow and study in the

lab, because they tend to die. But cancer cells live much

longer and are harder to kill, so scientists often use them. [Katherine] Schaefer was looking for drugs to treat the inflammation

seen in Crohn's disease and ulcerative colitis, both of which

cause pain and diarrhea.

She was testing a compound called a PPAR-gamma modulator.

It would never normally have been thought of as a cancer drug,

or in fact a drug of any kind. "I made a calculation error and used a lot more than I

should have. And my cells died," Schaefer said. A colleague overheard her complaining. "The co-author on my

paper said,' Did I hear you say you killed some cancer?' I said

'Oh', and took a closer look." They ran several tests and found the compound killed

"pretty much every epithelial tumor cell lines we have seen,"

Schaefer said. Epithelial cells line organs such as the colon,

and also make up skin. It also killed colon tumors in mice without making the mice

sick, they reported in the journal International Cancer


[image: University of Rochester medical researchers]

Why a federal judge ordered White House to restore Jim Acosta's press badge

A federal judge ruled that the Trump administration likely violated the reporter's Fifth Amendment rights when it stripped his press credentials earlier this month.

WASHINGTON, DC - NOVEMBER 16: CNN chief White House correspondent Jim Acosta (R) returns to the White House with CNN Washington bureau chief Sam Feist after Federal judge Timothy J. Kelly ordered the White House to reinstate his press pass November 16, 2018 in Washington, DC. CNN has filed a lawsuit against the White House after Acosta's press pass was revoked after a dispute involving a news conference last week. (Photo by Alex Wong/Getty Images)
Politics & Current Affairs
  • Acosta will be allowed to return to the White House on Friday.
  • The judge described the ruling as narrow, and didn't rule one way or the other on violations of the First Amendment.
  • The case is still open, and the administration may choose to appeal the ruling.
Keep reading Show less

Russian reporters discover 101 'tortured' whales jammed in offshore pens

Protected animals are feared to be headed for the black market.

Politics & Current Affairs
  • Russian news network discovers 101 black-market whales.
  • Orcas and belugas are seen crammed into tiny pens.
  • Marine parks continue to create a high-price demand for illegal captures.
Keep reading Show less

Water may be an inevitable result of the process that forms rocky planets

New research identifies an unexpected source for some of earth's water.

Surprising Science
  • A lot of Earth's water is asteroidal in origin, but some of it may come from dissolved solar nebula gas.
  • Our planet hides majority of its water inside: two oceans in the mantle and 4–5 in the core.
  • New reason to suspect that water is abundant throughout the universe.
Keep reading Show less